Tenhunen R, Iivanainen M, Kovanen J
Acta Neurol Scand. 1978 Dec;58(6):366-73. doi: 10.1111/j.1600-0404.1978.tb02901.x.
Beta-2-microglobulin was measured in specimens of cerebrospinal fluid (CSF) collected from 167 patients classified in 14 diagnostic categories at an outpatient Department of Neurology. In the control group of 29 subjects without any obvious disease of the nervous system, the concentration of beta-2-microglobulin was 1.15 +/- 0.37 mg/1 (M +/- s.d.). The concentration was almost significantly elevated in the groups with fresh brain infarct, central nervous system infection, and polyneuropathy. The serum concentrations of beta-2-microglobulin did not differ significantly among these diagnostic categories. The mean ratio between CSF and serum beta-2-microglobulin was 0.79 +/- 0.32 in the control group and more than 1.0 in the patients with brain infarcts, CNS infections and spinal paresis, but the differences were not statistically significant.
在一家神经内科门诊,对167例分属14种诊断类别的患者采集脑脊液(CSF)样本,测定其中的β2微球蛋白。在29名无任何明显神经系统疾病的对照组受试者中,β2微球蛋白浓度为1.15±0.37mg/1(均值±标准差)。在新发脑梗死、中枢神经系统感染和多发性神经病组中,该浓度几乎显著升高。这些诊断类别之间的血清β2微球蛋白浓度无显著差异。对照组CSF与血清β2微球蛋白的平均比值为0.79±0.32,脑梗死、中枢神经系统感染和脊髓麻痹患者的该比值大于1.0,但差异无统计学意义。